These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 24918581)
1. QKI impairs self-renewal and tumorigenicity of oral cancer cells via repression of SOX2. Lu W; Feng F; Xu J; Lu X; Wang S; Wang L; Lu H; Wei M; Yang G; Wang L; Lu Z; Liu Y; Lei X Cancer Biol Ther; 2014 Sep; 15(9):1174-84. PubMed ID: 24918581 [TBL] [Abstract][Full Text] [Related]
2. NF-κB-regulated miR-155, via repression of QKI, contributes to the acquisition of CSC-like phenotype during the neoplastic transformation of hepatic cells induced by arsenite. Chen C; Luo F; Yang Q; Wang D; Yang P; Xue J; Dai X; Liu X; Xu H; Lu J; Zhang A; Liu Q Mol Carcinog; 2018 Apr; 57(4):483-493. PubMed ID: 29240254 [TBL] [Abstract][Full Text] [Related]
4. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. Bourguignon LY; Wong G; Earle C; Chen L J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005 [TBL] [Abstract][Full Text] [Related]
5. Cell division patterns and chromosomal segregation defects in oral cancer stem cells. Kaseb HO; Lewis DW; Saunders WS; Gollin SM Genes Chromosomes Cancer; 2016 Sep; 55(9):694-709. PubMed ID: 27123539 [TBL] [Abstract][Full Text] [Related]
6. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State. Chien CS; Wang ML; Chu PY; Chang YL; Liu WH; Yu CC; Lan YT; Huang PI; Lee YY; Chen YW; Lo WL; Chiou SH Cancer Res; 2015 Jun; 75(12):2553-65. PubMed ID: 25858147 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA Zhao X; Wu J; Li Y; Ye F; Wang C Bioengineered; 2021 Dec; 12(1):8698-8708. PubMed ID: 34697986 [TBL] [Abstract][Full Text] [Related]
8. VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug. Kim M; Jang K; Miller P; Picon-Ruiz M; Yeasky TM; El-Ashry D; Slingerland JM Oncogene; 2017 Sep; 36(36):5199-5211. PubMed ID: 28504716 [TBL] [Abstract][Full Text] [Related]
9. USP14 promotes the cancer stem-like cell properties of OSCC via promoting SOX2 deubiquitination. Liu C; Zhou S; Tang W Oral Dis; 2024 Oct; 30(7):4255-4265. PubMed ID: 38376172 [TBL] [Abstract][Full Text] [Related]
11. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2. Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934 [TBL] [Abstract][Full Text] [Related]
12. miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells. Mukohyama J; Isobe T; Hu Q; Hayashi T; Watanabe T; Maeda M; Yanagi H; Qian X; Yamashita K; Minami H; Mimori K; Sahoo D; Kakeji Y; Suzuki A; Dalerba P; Shimono Y Cancer Res; 2019 Oct; 79(20):5151-5158. PubMed ID: 31416845 [TBL] [Abstract][Full Text] [Related]
13. Jmjd2c maintains the ALDH Wang M; Hu Y; Cai F; Guo L; Mao Y; Zhang Y Cancer Biol Ther; 2024 Dec; 25(1):2373447. PubMed ID: 38975736 [TBL] [Abstract][Full Text] [Related]
14. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells. Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337 [No Abstract] [Full Text] [Related]
15. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2. Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional repressor GATA binding 1-mediated repression of SRY-box 2 expression suppresses cancer stem cell functions and tumor initiation. Gong X; Liu W; Wu L; Ma Z; Wang Y; Yu S; Zhang J; Xie H; Wei G; Ma F; Lu L; Chen L J Biol Chem; 2018 Nov; 293(48):18646-18654. PubMed ID: 30315105 [TBL] [Abstract][Full Text] [Related]
17. Autophagy regulates the cancer stem cell phenotype of head and neck squamous cell carcinoma through the noncanonical FOXO3/SOX2 axis. Chen Y; Zhao H; Liang W; Jiang E; Zhou X; Shao Z; Liu K; Shang Z Oncogene; 2022 Jan; 41(5):634-646. PubMed ID: 34795388 [TBL] [Abstract][Full Text] [Related]
18. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells. Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866 [TBL] [Abstract][Full Text] [Related]
19. Sox2 expression involvement in the oncogenicity and radiochemoresistance of oral cancer stem cells. Chou MY; Hu FW; Yu CH; Yu CC Oral Oncol; 2015 Jan; 51(1):31-9. PubMed ID: 25456004 [TBL] [Abstract][Full Text] [Related]
20. Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer. Kuo HY; Hsu HT; Chen YC; Chang YW; Liu FT; Wu CW Glycobiology; 2016 Feb; 26(2):155-65. PubMed ID: 26447186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]